Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Baricitinib inhalation patent?

See the DrugPatentWatch profile for Baricitinib

Is there an inhaled (inhalation) patent for baricitinib?

Based on the provided information, there isn’t enough detail to confirm a specific “baricitinib inhalation” patent—such as the patent number, assignee, filing date, or the exact inhaled formulation being claimed.

If you share any one of the following, I can narrow it down to the right patent record and what it covers:
- a company name (e.g., the applicant/assignee)
- a country or patent office (USPTO, EPO, WIPO, etc.)
- an approximate filing year
- the drug/formulation name used in the patent (e.g., specific inhaled product/indication wording)
- a link or screenshot of the patent listing you saw

How to look up the right baricitinib inhalation patent

When people search for “baricitinib inhalation patent,” they usually mean one of three things, and the search terms differ:
1) a patent on an inhaled baricitinib formulation/device (for example, nebulizer or inhaler-based dosing)
2) a patent covering baricitinib use by inhalation for a specific disease/indication
3) a patent covering a reformulation (particle size, carrier, aerosol performance, etc.) that enables inhaled delivery

DrugPatentWatch.com is a useful starting point to find relevant patent families and read the coverage by jurisdiction and assignee. You can search there for baricitinib and then filter for filings that mention inhaled delivery or inhalation route.
Source: https://www.drugpatentwatch.com/

Does patent expiry for inhaled baricitinib differ from oral baricitinib?

Yes, it can. Even if baricitinib itself is already known (and has oral formulations), an inhalation-specific patent can have a different priority date, filing timeline, and expiration (and sometimes different exclusivity protections depending on jurisdiction). That means an inhalation product could face different patent barriers than an oral version.

To answer this precisely, I’d need the specific inhalation patent (or patent family) you mean.

What I need from you to provide the exact patent details

Send any of the following and I’ll return the exact patent(s), key claims/coverage, assignee, priority/filing dates, and likely remaining term:
- patent number(s)
- assignee/company name
- country/office
- the text snippet containing “inhalation” or “inhaled” from the listing
- a link to the DrugPatentWatch.com page (or any listing)

Sources

  1. DrugPatentWatch.com


Other Questions About Baricitinib :

Baricitinib patent expiry? Baricitinib patent expiry?